Abstract
Profound thrombocytopenia is a rare complication of abciximab administration -- one that is associated with increased bleeding rates.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1056/jc200009150000003
Journal: NEJM Journal Watch | Publication Date: Sep 15, 2000 |
Profound thrombocytopenia is a rare complication of abciximab administration -- one that is associated with increased bleeding rates.
Join us for a 30 min session where you can share your feedback and ask us any queries you have